alexa Characterization of the Murine K14-FynY528F Transgenic SCC Model Provides Novel Therapeutic Insights

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Characterization of the Murine K14-FynY528F Transgenic SCC Model Provides Novel Therapeutic Insights

Cutaneous squamous cell carcinoma (cSCC) is one of the most common human malignancies. The development of mouse models that accurately recapitulate the human condition is crucial for testing novel therapeutic modalities. In this article we discuss the utility of the K14-Fyn-Y528F transgenic mouse as a model for cSCC and actinic keratosislike precursor lesions and its use in testing novel small molecule kinase inhibitors topically.

Citation: Gober MD, Seykora JT (2015) Characterization of the Murine K14- FynY528F Transgenic SCC Model Provides Novel Therapeutic Insights. Med chem 5:149-151. doi: 10.4172/2161-0444.1000256

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords